United States · FDA National Drug Code directory
Spironolactone and hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72888-040_5b333a2a-14ce-8106-e063-6394a90aff6c
- Product NDC
- 72888-040
- Form
- TABLET
- Composition / generic term
- Spironolactone and hydrochlorothiazide
- Labeler
- Advagen Pharma Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260910
- Source listing expiry
- 20271231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (72888-040-01) · 72888-040-01
- 100 TABLET in 1 BOTTLE (72888-040-02) · 72888-040-02
- 1000 TABLET in 1 BOTTLE (72888-040-03) · 72888-040-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →